Medicine in the marketplace: clinician and patient views on commercial influences on assisted reproductive technologies
Siun Gallagher,Sara Attinger,Angie Sassano,Elizabeth Sutton,Ian Kerridge,Ainsley Newson,Bobbie Farsides,Karin Hammarberg,Roger Hart,Emily Jackson,William Ledger,Christopher Mayes,Catherine Mills,Sarah Norcross,Robert J Norman,Luk Rombauts,Catherine Waldby,Anusch Yazdani,Wendy Lipworth
DOI: https://doi.org/10.1016/j.rbmo.2024.103850
IF: 4.567
2024-01-31
Reproductive BioMedicine Online
Abstract:Research question To investigate the views and experiences of patient and expert stakeholders on the positive and negative impacts of commercial influences on the provision of assisted reproductive technology services and to document their suggestions for governance reforms. Design Semi-structured interviews with 31ART industry experts from across Australia and New Zealand and 25 ART patients from metropolitan and regional Australia, between September 2020 and September 2021. Data were analysed using thematic analysis. Results Expert and patient participants considered that commercial forces influence provision of ART in a number of positive ways—increasing sustainability, ensuring consistency in standards and providing patients with greater choice. Participants also considered commercial forces to have a number of negative impacts, including increased costs to government and patients; excessive use of interventions that lack sufficient evidence to be considered part of standard care; inadequately informed consent (particularly with regard to financial information); and threats to patient-provider relationships and patient-centred care. Participants varied in whether they believed that professional self-regulation is sufficient. While recognising the benefits of commercial investment in health care, many considered that regulatory reforms, as well as organisational cultural initiatives, are needed as means to ensure the primacy of patient wellbeing. Conclusions The views expressed in this study should be systematically and critically examined to derive insights into how best to govern ART. These insights may also inform the design and delivery of other types of healthcare that are provided in the private sector.
obstetrics & gynecology,reproductive biology